MARKET

IPCIF

IPCIF

Intellipharmaceu
EXMKT
0.100
NaN%
Closed 09:30 07/17 EDT
OPEN
--
PREV CLOSE
0.100
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.300
52 WEEK LOW
0.024
MARKET CAP
3.31M
P/E (TTM)
-0.3955
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at IPCIF last week (0708-0712)?
Weekly Report · 2d ago
Weekly Report: what happened at IPCIF last week (0701-0705)?
Weekly Report · 07/08 11:59
Weekly Report: what happened at IPCIF last week (0624-0628)?
Weekly Report · 07/01 11:59
Weekly Report: what happened at IPCIF last week (0617-0621)?
Weekly Report · 06/24 12:09
Weekly Report: what happened at IPCIF last week (0610-0614)?
Weekly Report · 06/17 11:58
Intellipharmaceutics Hit by Market Downgrade
TipRanks · 06/14 21:20
Weekly Report: what happened at IPCIF last week (0603-0607)?
Weekly Report · 06/10 12:01
Weekly Report: what happened at IPCIF last week (0527-0531)?
Weekly Report · 06/03 12:04
More
About IPCIF
Intellipharmaceutics International Inc. is a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to a range of existing and new pharmaceuticals. It has developed several drug delivery systems based on this technology platform, with a pipeline of products in various stages of development in therapeutic areas that include neurology, cardiovascular, gastrointestinal tract (GIT), diabetes and pain. Its product portfolio includes Oxycodone Hydrochloride ER, Regabatin, Dexmethylphenidate ER, Metformin ER, Venlafaxine ER, Pantoprazole ER, Quetiapine ER, Lamotrigine ER, Levetiracetam ER, Desvenlafaxine ER, Ranolazine ER, and Carvedilol ER. Its product portfolio includes both new products and controlled-release generic products. It also provides analytical services.

Webull offers Intellipharmaceutics International Inc stock information, including EXMKT: IPCIF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IPCIF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IPCIF stock methods without spending real money on the virtual paper trading platform.